| Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics U Anand, A Dey, AKS Chandel, R Sanyal, A Mishra, DK Pandey, ... Genes & Diseases, 2022 | 329 | 2022 |
| Encyclopedia of bioinformatics and computational biology SC Peter, JK Dhanjal, V Malik, N Radhakrishnan, M Jayakanthan, ... Ranganathan, S., Grib-skov, M., Nakai, K., Schönbach, C., Eds, 661-676, 2019 | 279 | 2019 |
| Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity V Kumar, JK Dhanjal, SC Kaul, R Wadhwa, D Sundar Journal of Biomolecular Structure and Dynamics 39 (11), 3842-3854, 2021 | 194 | 2021 |
| Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells V Kumar, JK Dhanjal, P Bhargava, A Kaul, J Wang, H Zhang, SC Kaul, ... Journal of Biomolecular Structure and Dynamics 40 (1), 1-13, 2022 | 166 | 2022 |
| Quantitative structure-activity relationship (QSAR): modeling approaches to biological applications SC Peter, JK Dhanjal, V Malik, N Radhakrishnan, M Jayakanthan, ... Academic Press, 2019 | 95 | 2019 |
| Molecular characterization and enhancement of anticancer activity of caffeic acid phenethyl ester by γ cyclodextrin R Wadhwa, N Nigam, P Bhargava, JK Dhanjal, S Goyal, A Grover, ... Journal of Cancer 7 (13), 1755, 2016 | 82 | 2016 |
| Development of dual inhibitors against Alzheimer’s disease using fragment-based QSAR and molecular docking M Goyal, JK Dhanjal, S Goyal, C Tyagi, R Hamid, A Grover BioMed research international 2014, 2014 | 52 | 2014 |
| Marine carotenoid fucoxanthin possesses anti-metastasis activity: Molecular evidence S Garg, S Afzal, A Elwakeel, D Sharma, N Radhakrishnan, JK Dhanjal, ... Marine drugs 17 (6), 338, 2019 | 49 | 2019 |
| Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2022 U Anand, A Dey, AKS Chandel, R Sanyal, A Mishra, DK Pandey, ... Press.[Google Scholar], 0 | 48* | |
| Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's JK Dhanjal, S Sharma, A Grover, A Das Biomedicine & Pharmacotherapy 71, 146-152, 2015 | 45 | 2015 |
| Computational design of novel flavonoid analogues as potential AChE inhibitors: analysis using group-based QSAR, molecular docking and molecular dynamics simulations C Vats, JK Dhanjal, S Goyal, N Bharadvaja, A Grover Structural Chemistry 26 (2), 467-476, 2015 | 43 | 2015 |
| Combination of withaferin-A and CAPE provides superior anticancer potency: bioinformatics and experimental evidence to their molecular targets and mechanism of action AN Sari, P Bhargava, JK Dhanjal, JF Putri, N Radhakrishnan, S Shefrin, ... Cancers 12 (5), 1160, 2020 | 41 | 2020 |
| Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental … D Sundar, Y Yu, SP Katiyar, JF Putri, JK Dhanjal, J Wang, AN Sari, ... Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019 | 36 | 2019 |
| Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosispyrazinamidase enzyme and pyrazinamide susceptibility C Vats, JK Dhanjal, S Goyal, A Gupta, N Bharadvaja, A Grover BMC genomics 16, 1-11, 2015 | 35 | 2015 |
| Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2 JK Dhanjal, AK Sreenidhi, K Bafna, SP Katiyar, S Goyal, A Grover, ... PloS one 10 (8), e0134691, 2015 | 35 | 2015 |
| Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence JK Dhanjal, N Nigam, S Sharma, A Chaudhary, SC Kaul, A Grover, ... BMC cancer 14, 1-12, 2014 | 35 | 2014 |
| Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides JK Dhanjal, V Kumar, S Garg, C Subramani, S Agarwal, J Wang, H Zhang, ... International journal of biological macromolecules 184, 297-312, 2021 | 34 | 2021 |
| Identifying synthetic lethal targets using CRISPR/Cas9 system JK Dhanjal, N Radhakrishnan, D Sundar Methods 131, 66-73, 2017 | 33 | 2017 |
| Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia L Rani, N Mathur, R Gupta, A Gogia, G Kaur, JK Dhanjal, D Sundar, ... Clinical epigenetics 9, 1-14, 2017 | 29 | 2017 |
| Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers JF Putri, P Bhargava, JK Dhanjal, T Yaguchi, D Sundar, SC Kaul, ... Journal of Experimental & Clinical Cancer Research 38, 1-15, 2019 | 27 | 2019 |
Durai SundarProfessor, Biochemical Engineering and Biotechnology, IIT Delhi, India在 dbeb.iitd.ac.in 的电子邮件经过验证
